Sage Journals: Discover world-class research

Retricted access

Review article

First published 2010-1

Review: Saxagliptin: a review

Marc Evans

The British Journal of Diabetes & Vascular Disease

Retricted access

Research article

First published 2010-6

Saxagliptin: A New Dipeptidyl Peptidase 4 Inhibitor for Type 2 Diabetes

Nancy L Borja-Hart, Karen L Whalen

Annals of Pharmacotherapy

Open access

Research article

First published 2011

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Jay Shubrook, Randall Colucci, Aili Guo [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Open access

Review article

First published 2013

Saxagliptin and Metformin in Fixed Combination for the Treatment of Type 2 Diabetes in Adults

Molly G. Minze, Mary S. Klein, Brian T. Terrell

Clinical Medicine Insights: Endocrinology and Diabetes

Free access

Other

First published 2011-4

Safety and efficacy of saxagliptin in combination with submaximal sulphonylurea versus up-titrated sulphonylurea over 76 weeks

Antonio R Chacra, Gerry H Tan, Shoba Ravichandran [...]

Diabetes & Vascular Disease Research

Free access

Other

First published 2011-4

Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus

Priscilla L Hollander, Jia Li, Robert Frederich [...]

Diabetes & Vascular Disease Research

Retricted access

Review article

First published 2018-1

Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes

Valerie Azzopardi Coppenrath, Tasmina Hydery

Annals of Pharmacotherapy

Open access

Research article

First published 2020

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II

Enrico Torre, Giacomo Matteo Bruno, Sergio Di Matteo [...]

Health Services Insights

Open access

Research article

First published 2021-1

Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia

Mengistu Bekele, Ole Frithjof Norheim, Alemayehu Hailu

MDM Policy & Practice

Retricted access

Research article

First published 2010-5

Saxagliptin: New Therapy for Type 2 Diabetes

Jill K Logan, Alisa K EscañO

Journal of Pharmacy Technology

Search results